Copenhagen Prospective Personalized Oncology (CoPPO) - Trial NCT02290522
Access comprehensive clinical trial information for NCT02290522 through Pure Global AI's free database. This phase not specified trial is sponsored by Ulrik Lassen and is currently Recruiting. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ulrik Lassen
Rigshospitalet, Denmark
Timeline & Enrollment
N/A
May 01, 2013
Dec 01, 2023
Primary Outcome
Median progression free survival (PFS)
Summary
Patients with advanced solid tumors referred to the Phase 1 Unit are offered mapping of GA
 for identification of pts who could benefit from a personalized treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02290522
Non-Device Trial